+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID06298448

Studying How Mepolizumab Affects Nasal Microbiome and Immune Response in Eosinophilic Granulomatosis With Polyangiitis and Related Conditions

Led by University Medical Center Groningen · Updated on 2024-03-07

150

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the role of nasal microbiome changes and immune responses in Eosinophilic Granulomatosis with Polyangiitis eGPA, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps CRSwNP. These airway diseases involve eosinophils and interleukin-5 in their development, with eGPA affecting other organs as well. The study focuses on how nasal microbiome imbalance, particularly involving S. Aureus, may influence disease symptoms and progression. The study compares groups of eGPA patients before and after treatment with mepolizumab, a medication targeting interleukin-5, alongside asthma patients, CRSwNP patients, and healthy individuals. Researchers will perform laboratory tests before and after mepolizumab treatment to assess its impact on immune parameters and nasal microbiome profiles. Some groups will not receive mepolizumab, serving as comparators. Participants will undergo evaluations of their nasal microbiome and both local and systemic immune responses, with the primary outcome being the change in nasal microbiome profiles three months after starting mepolizumab. The study includes clinical assessments such as endoscopy or CT scans for nasal polyps, lung function tests for asthma, and criteria-based diagnosis confirmation. The involvement period and follow-up details align with monitoring changes related to the medication and disease status.

CONDITIONS

Brief Title

eGPA and Local Inflammation Within the Ear, Nose and Throat Area

Research Team

A

Abraham Rutgers, MD-PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here